Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conor Calnan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|June 15, 2026
CRISPR-screen informed engineered T cell therapiesKarrie Wong, Conor Calnan, Micah J Benson
The Journal of Biological Chemistry|July 13, 2016
Structure and Glycan Binding of a New Cyanovirin-N HomologElena Matei, Rohan Basu, William Furey, et al.
Frontiers in Immunology|May 4, 2026
Tumor reactivity assessment using clonal expression reveals tumor reactive CD8<sup>+</sup> T cell heterogeneity across solid tumorsDavid Monteiro, Jack Denebeim, Anne E Dodson, et al.
The Journal of Clinical Investigation|December 15, 2023
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screensMichael R Schlabach, Sharon Lin, Zachary R Collester, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|June 15, 2026
CRISPR-screen informed engineered T cell therapiesKarrie Wong, Conor Calnan, Micah J Benson
The Journal of Biological Chemistry|July 13, 2016
Structure and Glycan Binding of a New Cyanovirin-N HomologElena Matei, Rohan Basu, William Furey, et al.
Frontiers in Immunology|May 4, 2026
Tumor reactivity assessment using clonal expression reveals tumor reactive CD8<sup>+</sup> T cell heterogeneity across solid tumorsDavid Monteiro, Jack Denebeim, Anne E Dodson, et al.
The Journal of Clinical Investigation|December 15, 2023
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screensMichael R Schlabach, Sharon Lin, Zachary R Collester, et al.
Pageof 1